Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001425587 | SCV001628219 | likely benign | Spongy degeneration of central nervous system | 2024-02-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035300 | SCV004910622 | uncertain significance | Inborn genetic diseases | 2023-10-17 | criteria provided, single submitter | clinical testing | The c.806C>T (p.T269M) alteration is located in exon 6 (coding exon 6) of the ASPA gene. This alteration results from a C to T substitution at nucleotide position 806, causing the threonine (T) at amino acid position 269 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Department of Molecular Biology and Genetics, |
RCV001251015 | SCV001424925 | uncertain significance | Fraser syndrome 3 | no assertion criteria provided | research |